187 related articles for article (PubMed ID: 23333860)
1. Lactocepin as a protective microbial structure in the context of IBD.
Hörmannsperger G; von Schillde MA; Haller D
Gut Microbes; 2013; 4(2):152-7. PubMed ID: 23333860
[TBL] [Abstract][Full Text] [Related]
2. Lactocepin secreted by Lactobacillus exerts anti-inflammatory effects by selectively degrading proinflammatory chemokines.
von Schillde MA; Hörmannsperger G; Weiher M; Alpert CA; Hahne H; Bäuerl C; van Huynegem K; Steidler L; Hrncir T; Pérez-Martínez G; Kuster B; Haller D
Cell Host Microbe; 2012 Apr; 11(4):387-96. PubMed ID: 22520466
[TBL] [Abstract][Full Text] [Related]
3. Posttranslational inhibition of proinflammatory chemokine secretion in intestinal epithelial cells: implications for specific IBD indications.
Hörmannsperger G; Clavel T; Hoffmann M; Reiff C; Kelly D; Loh G; Blaut M; Hölzlwimmer G; Haller D
J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S10-5. PubMed ID: 20562631
[TBL] [Abstract][Full Text] [Related]
4. Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease.
Hörmannsperger G; Haller D
Int J Med Microbiol; 2010 Jan; 300(1):63-73. PubMed ID: 19828372
[TBL] [Abstract][Full Text] [Related]
5. Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation.
Hoermannsperger G; Clavel T; Hoffmann M; Reiff C; Kelly D; Loh G; Blaut M; Hölzlwimmer G; Laschinger M; Haller D
PLoS One; 2009; 4(2):e4365. PubMed ID: 19197385
[TBL] [Abstract][Full Text] [Related]
6. Live and heat-killed probiotic Lactobacillus casei Lbs2 protects from experimental colitis through Toll-like receptor 2-dependent induction of T-regulatory response.
Thakur BK; Saha P; Banik G; Saha DR; Grover S; Batish VK; Das S
Int Immunopharmacol; 2016 Jul; 36():39-50. PubMed ID: 27107798
[TBL] [Abstract][Full Text] [Related]
7. A component of polysaccharide peptidoglycan complex on Lactobacillus induced an improvement of murine model of inflammatory bowel disease and colitis-associated cancer.
Matsumoto S; Hara T; Nagaoka M; Mike A; Mitsuyama K; Sako T; Yamamoto M; Kado S; Takada T
Immunology; 2009 Sep; 128(1 Suppl):e170-80. PubMed ID: 19740306
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulation and Generation of Tolerogenic Dendritic Cells by Probiotic Bacteria in Patients with Inflammatory Bowel Disease.
Ghavami SB; Yadegar A; Aghdaei HA; Sorrentino D; Farmani M; Mir AS; Azimirad M; Balaii H; Shahrokh S; Zali MR
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872480
[TBL] [Abstract][Full Text] [Related]
9. The effects of heat-killed wild-type Lactobacillus casei Shirota on allergic immune responses in an allergy mouse model.
Lim LH; Li HY; Huang CH; Lee BW; Lee YK; Chua KY
Int Arch Allergy Immunol; 2009; 148(4):297-304. PubMed ID: 19001789
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Lactobacillus casei on Experimental Porcine Inflammatory Bowel Disease Induced by Dextran Sodium Sulphate.
Bureš J; Kohoutová D; Květina J; Radochová V; Pavlík M; Tichý A; Rejchrt S; Kopáčová M; Douda T; Vysloužil D; Pejchal J
Acta Medica (Hradec Kralove); 2021; 64(2):85-90. PubMed ID: 34331427
[TBL] [Abstract][Full Text] [Related]
11. Probiotic mixture supplementation in the preventive management of trinitrobenzenesulfonic acid-induced inflammation in a murine model.
Traina G; Menchetti L; Rappa F; Casagrande-Proietti P; Barbato O; Leonardi L; Carini F; Piro F; Brecchia G
J Biol Regul Homeost Agents; 2016; 30(3):895-901. PubMed ID: 27655518
[TBL] [Abstract][Full Text] [Related]
12. New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches.
Alard J; Peucelle V; Boutillier D; Breton J; Kuylle S; Pot B; Holowacz S; Grangette C
Benef Microbes; 2018 Feb; 9(2):317-331. PubMed ID: 29488412
[TBL] [Abstract][Full Text] [Related]
13. Effect of dietary probiotics on colon length in an inflammatory bowel disease-induced murine model: A meta-analysis.
Ahn SI; Cho S; Choi NJ
J Dairy Sci; 2020 Feb; 103(2):1807-1819. PubMed ID: 31785874
[TBL] [Abstract][Full Text] [Related]
14. Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease.
Reiff C; Delday M; Rucklidge G; Reid M; Duncan G; Wohlgemuth S; Hörmannsperger G; Loh G; Blaut M; Collie-Duguid E; Haller D; Kelly D
Inflamm Bowel Dis; 2009 Nov; 15(11):1721-36. PubMed ID: 19639558
[TBL] [Abstract][Full Text] [Related]
15. Lactobacillus casei LH23 modulates the immune response and ameliorates DSS-induced colitis via suppressing JNK/p-38 signal pathways and enhancing histone H3K9 acetylation.
Liu M; Ding J; Zhang H; Shen J; Hao Y; Zhang X; Qi W; Luo X; Zhang T; Wang N
Food Funct; 2020 Jun; 11(6):5473-5485. PubMed ID: 32495801
[TBL] [Abstract][Full Text] [Related]
16.
Dou X; Qiao L; Chang J; Yan S; Song X; Chen Y; Xu Q; Xu C
Food Funct; 2021 Nov; 12(23):12022-12035. PubMed ID: 34755743
[TBL] [Abstract][Full Text] [Related]
17. Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment.
Zakostelska Z; Kverka M; Klimesova K; Rossmann P; Mrazek J; Kopecny J; Hornova M; Srutkova D; Hudcovic T; Ridl J; Tlaskalova-Hogenova H
PLoS One; 2011; 6(11):e27961. PubMed ID: 22132181
[TBL] [Abstract][Full Text] [Related]
18. Lactobacillus paracasei subsp. paracasei B21060 suppresses human T-cell proliferation.
Peluso I; Fina D; Caruso R; Stolfi C; Caprioli F; Fantini MC; Caspani G; Grossi E; Di Iorio L; Paone FM; Pallone F; Monteleone G
Infect Immun; 2007 Apr; 75(4):1730-7. PubMed ID: 17242060
[TBL] [Abstract][Full Text] [Related]
19. Flexible cytokine production by macrophages and T cells in response to probiotic bacteria: a possible mechanism by which probiotics exert multifunctional immune regulatory activities.
Shida K; Nanno M; Nagata S
Gut Microbes; 2011; 2(2):109-14. PubMed ID: 21637028
[TBL] [Abstract][Full Text] [Related]
20. Antigen-presenting cells exposed to Lactobacillus acidophilus NCFM, Bifidobacterium bifidum BI-98, and BI-504 reduce regulatory T cell activity.
Schmidt EG; Claesson MH; Jensen SS; Ravn P; Kristensen NN
Inflamm Bowel Dis; 2010 Mar; 16(3):390-400. PubMed ID: 19714743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
